SAFETY RISK MANAGEMENT
Through a focus on risk assessment, the Heads of Safety and PV will debate and brainstorm about the needed organizational structure, technology infrastructure, regulatory approach, ways to improve post-market authorization, and risk in the drug development life-cycle.
NEXT GEN TECH & DATA
Innovation in technology, data, evidence, pharmacoepidemiology, artificial intelligence and machine learning are the key areas explored by the industry in our program as they promote approaches in data collection methods, signal detection, automation, adoption and implementation.
TFrom value assessment to regulatory harmonization, the Global PV focus of our program will address the approached to internationalization of pharmacovigilance approaches as the industry penetrates new markets for medicines and medical devices.
Bringing together toxicology, translational data, non-clinical studies, trial design, and model selection to help your company increase the accuracy of safety predictions.
MEDICAL DEVICE SAFETY
No other conference addresses the evolving landscape of safety for medical devices from a practical and innovative perspective. This bold focus of our program will bring pharma, biotechs, medical device developers and regulatory agencies to discuss the need for modern regulation that meet patient safety needs.